Abstract
Diagnostic imaging can play an important role in detecting and staging esophageal cancer. Current diagnostic workup consists of barium esophagography, endoscopy/endoscopic ultrasonography (EUS), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). CT, EUS, MRI, and PET should be considered complementary modalities. In combination, they are crucial to determine the most appropriate treatment for patients with esophageal cancer.
This chapter describes the diagnostic imaging, mainly of CT and MRI, and relevant anatomy of the esophagus for clinical decision-making with regard to esophageal cancers. EUS precisely shows tumor invasion mainly localized in the esophageal wall (defined as T1–3). On the other hand, cross-sectional imaging such as CT and MRI are useful to detect tumor invasion to the adjacent structures beyond the adventitia (defined as T4). Currently, regional lymph node metastases are evaluated using EUS, CT, and/or FDG-PET. Detection of metastatic lymphadenopathies on CT depends primarily on nodal size (size criteria) although size is known to be an insensitive parameter. MRI’s role to assess regional nodal metastasis is limited so far. CT is currently the best diagnostic method to detect metastases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
American Joint Committee on Cancer, Edge SB, et al. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010.
Mancuso AA. Cervical esophagus. In: Mancuso AA, editor. Head and neck radiology. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer; 2011.
Hasegawa N, Niwa Y, Arisawa T, et al. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoesopic ultrasonography. Gastrointest Endosc. 1996;39:388–92.
Postlethwait RW. Carcinoma of the thoracic esophagus. Surg Clin North Am. 1983;63:933–40.
Kim TJ, Kim HY, Lee KW, et al. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29:403–21.
Levine MS, Rubesin SE. Diseases of the esophagus: diagnosis with esophagography. Radiology. 2005;237:414–27.
The Japan Esophageal Society. Japanese classification of esophageal cancer. 10th ed. Tokyo: Kanehara Co. Ltd; 2008.
Levine MS, Chu P, Furth EE, et al. Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis. AJR Am J Roentgenol. 1997;168:1423–6.
Levine MS, Halvorsen RA. Esophageal carcinoma. In: Core RM, Levine MS, Laufer I, editors. Textbook of gastrointestinal radiology. Philadelphia: WB Saunders Co; 1994.
Wakelin SJ, Deans C, Crofts TJ, et al. A comparison of computerized tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophagogastric carcinoma. Eur J Radiol. 2002;41:161–7.
Preston ST, Clark GW, Martin IG, et al. Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma. Br J Surg. 2003;90:1220–4.
Holsher AH, Dittler HJ, Siewert JR. Staging of squamous esophageal cancer: accuracy and value. World J Surg. 1994;18:312–20.
van den Hoed RD, Feldberg MAM, van Leeuwen MS, et al. CT prediction of irresectability in esophageal carcinoma: value of additional patient positions and relation to patient outcome. Abdom Imaging. 1997;22:132–7.
Thompson WM, Halvorsen RA, Foster WL Jr, et al. Computed tomography for staging esophageal and gastroesophgaeal cancer: reevaluation. AJR Am J Roentgenol. 1983;141:951–8.
Halvorsen RA Jr, Thompson WM. Computed tomographic staging of gastrointestinal malignancies. I. Esophagus and stomach. Investig Radiol. 1987;22:2–16.
Umeoka S, Koyama T, Togashi K, et al. Esophageal cancer: evaluation with triple-phase dynamic CT - initial experience. Radiology. 2006;239:777–83.
Umeoka S, Okada T, Daido S, et al. “Early esophageal rim enhancement”: a new sign of esophageal cancer on dynamic CT. Eur J Radiol. 2013;82:459–63.
Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology. 2003;227:764–70.
Desai RK, Tagliabue JR, Wegryn SA, et al. CT evaluation of wall thickening in the alimentary tract. Radiographics. 1991;11:771–83.
Xia F, Mao J, Ding J, Yang H. Observation of normal appearance and wall thickness of esophagus on CT images. Eur J Radiol. 2009;72:406–11.
Liao ZX, Liu H, Komaki R. Target delineation for esophageal cancer. J Women’s Imaging. 2003;5:177–86.
Moss AA, Schnyder P, Thoeni RF, et al. Esophageal carcinoma: pretherapy staging by computed tomography. Am J Roentgenol. 1981;136:1051–6.
Noh HM, Fishman EK, Forastiere AA, et al. CT of the esophagus: spectrum of disease with emphasis on esophageal carcinoma. Radiographics. 1995;15:1113–34.
Van Rossum PSN, van Hillegersberg R, Lever FM, et al. Imaging strategies in the management of oesophageal cancer: what’s the role of MRI? Eur Radiol. 2013;23:1753–65.
Picus D, Balfe DM, Koehler RE, et al. Computed tomography in the staging of esophageal carcinoma. Radiology. 1983;46:433–8.
Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery. 1988;103:344–50.
Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol. 1991;156:297–302.
Quint LE, Bogot NR. Staging esophageal cancer. Cancer Imaging. 2008;8:S33–42. Sepec No A
Lefor AT, Merino MM, Steinberg SM, et al. Computerized tomographic prediction of extraluminal spread and prognostic implications of lesion width in esophageal cancer (abstr). Radiology. 1989;171:290.
Ruf G, Brobmann GF, Grosser G, et al. Wert der Computer-tomographie fur die Beurteiling der lokalen Operabilitat und die chirurgische Verfahrenswahl beim Oesophagus-carcinoom. Langenbecks Arch Chir. 1985;365:157–68.
Ogawa Y, Nischiyama K, Ikesoe J, et al. Preoperative assessment of tumor invasions of the intrathoracic esophageal carcinoma. In: Siewert JR, Holscher AH, editors. Diseases of the esophagus. 1st ed. New York: Springer; 1987. p. 203–6.
Sakurada A, Takahara T, Kwee IC, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol. 2009;19:1461–9.
Iyer RB, Silverman PM, Tamm EP, et al. Imaging in oncology from the University of Texas M.D. Anderson cancer center. Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol. 2003;181:785–93.
Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg. 1997;64:770–7.
Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–8.
Van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigation for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98:547–57.
Van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fluiorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22:3805–12.
Quint LE, Hepbum LM, Francis IR, et al. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–5.
Mandard AM, Chasle J, Marnay J, et al. Autopsy findings in 111 cases of esophageal cancer. Cancer. 1981;48:329–35.
Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluirodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168:417–24.
Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–10.
Downey RJ, Akhurst T, Ilson D, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of the prospective trial. J Clin Oncol. 2003;21:428.
Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am. 2000;10:471–85.
Carlisle JG, Quint LE, Francis IR, et al. Recurrent esophageal carcinoma: CT evaluation after esophagectomy. Radiology. 1993;189:271–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ojiri, H. (2020). Diagnostic Imaging of the Esophageal Cancer. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-15-4190-2_3
Download citation
DOI: https://doi.org/10.1007/978-981-15-4190-2_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4189-6
Online ISBN: 978-981-15-4190-2
eBook Packages: MedicineMedicine (R0)